Profile: Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

96.11EUR
5 May 2015
Change (% chg)

€0.33 (+0.34%)
Prev Close
€95.78
Open
€96.49
Day's High
€97.50
Day's Low
€96.01
Volume
56,076
Avg. Vol
39,428
52-wk High
€98.99
52-wk Low
€76.32

Search Stocks
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, such as bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, among others. In January 2014, it acquired 100% stake in BioFire Diagnostics Inc. In April 2014, it introduced chromID CARBA SMART, new bi-plate Petri dish.

Company Address

Biomerieux SA

5, rue des Aqueducs, BP 10
CRAPONNE     69290
P: +334.78872000
F: +334.78872090

Company Web Links

Search Stocks